# Role of Glutamine as Myocardial Protector in Elective On-Pump CABG Surgery With Low EF

> **NCT04560309** · PHASE3 · COMPLETED · sponsor: **National Cardiovascular Center Harapan Kita Hospital Indonesia** · enrollment: 60 (actual)

## Conditions studied

- Coronary Artery Bypass
- Cardiopulmonary Bypass
- Coronary Artery Disease

## Interventions

- **DRUG:** L-alanyl-L-glutamine dipeptide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04560309
- **Lead sponsor:** National Cardiovascular Center Harapan Kita Hospital Indonesia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2021-10-30
- **Final completion:** 2021-11-23
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04560309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04560309, "Role of Glutamine as Myocardial Protector in Elective On-Pump CABG Surgery With Low EF". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04560309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*